THRB and breast cancer: Simultaneously, cis9,trans11 isomer upregulated THRB suppressor and downregulated WT1 oncogene showing a small part of a PPAR action that in case of EFA-CLA leads to the observed reduction in proliferation of the breast cancer cells.